会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明授权
    • Purification of cadaverine using high boiling point solvent
    • 使用高沸点溶剂净化尸胺
    • US09556106B2
    • 2017-01-31
    • US14764109
    • 2013-01-28
    • CATHAY R&D CENTER CO., LTD.CATHAY INDUSTRIAL BIOTECH LTD.
    • Xiucai LiuCharlie LiuDuanfang DaiBingbing QinNaiqiang Li
    • C07C209/84C12P13/00
    • C07C209/84C12P13/001C07C211/09
    • One aspect of the invention relates to a method for the purification of cadaverine from an aqueous cadaverine composition comprising one or more involatile impurities, the method comprising obtaining cadaverine from evaporation or distillation of the aqueous cadaverine composition wherein one or more solvents are added to the evaporation/distillation system before the evaporation/distillation starts, during the evaporation/distillation and/or after the evaporation/distillation substantially stops when no more evaporation/distillation is observed; wherein the one or more solvents comprise at least one or more high boiling point (HBP) solvents. In certain embodiments, cadaverine may be evaporated/distilled at an unexpectedly lower heating temperature for an unexpectedly shorter heating time to provide a desired yield. Because cadaverine may decompose at high temperature, the unexpectedly lower heating temperature and unexpectedly shorter heating time decrease the undesired cadaverine decomposition. The methods disclosed herein provides unexpected high recovery rate (˜100%) in the evaporation/distillation of cadaverine at a larger scale at a lower heating temperature compared to conventional distillation methods. Thus, the method disclosed herein will be highly appreciated in the industrial production of cadaverine.
    • 本发明的一个方面涉及从包含一种或多种非挥发性杂质的水性尸胺组合物中纯化尸胺的方法,所述方法包括从蒸发或蒸馏水性尸胺组合物中获得尸胺,其中将一种或多种溶剂加入到蒸发中 在蒸发/蒸馏开始之前,蒸发/蒸馏期间和/或蒸发/蒸馏之后蒸馏/蒸馏系统在不再观察到蒸发/蒸馏的情况下基本停止; 其中所述一种或多种溶剂包含至少一种或多种高沸点(HBP)溶剂。 在某些实施方案中,可以在意想不到的较低加热温度下将尸胺蒸发/蒸馏,以期意外地更短的加热时间以提供所需的产率。 因为尸体可能会在高温下分解,出人意料地降低加热温度,而且意外的加热时间会缩短,从而减少不希望的尸体分解。 与常规蒸馏方法相比,本文所公开的方法在较低的加热温度下在较大规模的蒸发/蒸馏中提供了意想不到的高回收率(〜100%)。 因此,本文公开的方法将在尸胺的工业生产中被高度赞赏。
    • 2. 发明授权
    • Stabilized recombinant expression plasmid vector in hafnia alvei and applications thereof
    • 稳定的重组表达质粒载体在hafnia alvei及其应用
    • US09234203B2
    • 2016-01-12
    • US13795949
    • 2013-03-12
    • CATHAY INDUSTRIAL BIOTECH LTD.CATHAY R&D CENTER CO., LTD.
    • Zhenhua PangNaiqiang LiCharlie LiuXiucai Liu
    • C12N15/74C12P13/00C08G69/26
    • C12N9/88C07C211/09C08G69/26C12N15/74C12P13/00C12P13/001C12Y401/01018
    • One aspect of the present disclosure relates to a stabilized recombinant expression plasmid vector comprising a polynucleotide encoding an antitoxin gene which expresses a polypeptide that neutralizes a polypeptide toxic to a host cell, the toxic polypeptide being expressed by a toxin gene in the host cell, and a polynucleotide encoding a polypeptide expression product, and the stabilized recombinant expression plasmid vector is derived from a Hafnia alvei autonomously replicable backbone plasmid. Other aspects of the present disclosure relate to a transformant transformed with the stabilized recombinant expression plasmid vector disclosed herein, a method of producing biobased cadaverine using the transformant disclosed herein, and biobased cadaverine prepared by the method disclosed herein. Another aspect of the present disclosure relates to a polyamide formed using biobased cadaverine disclosed herein, and a composition thereof. Another aspect of the present disclosure relates to a method of preparing 1,5-diisocyanatopentane comprising preparing biobased cadaverine using the method disclosed herein and converting the biobased cadaverine to 1,5-diisocyanatopentane.
    • 本公开的一个方面涉及包含编码抗毒素基因的多核苷酸的稳定的重组表达质粒载体,所述多核苷酸表达中和宿主细胞毒性多肽的多肽,所述毒性多肽由所述宿主细胞中的毒素基因表达,以及 编码多肽表达产物的多核苷酸和稳定的重组表达质粒载体衍生自Hafnia alvei自主复制主链质粒。 本公开的其它方面涉及用本文公开的稳定的重组表达质粒载体转化的转化体,使用本文公开的转化体生产生物基的尸胺的方法,以及通过本文公开的方法制备的生物基尸胺。 本公开的另一方面涉及使用本文公开的生物基尸胺形成的聚酰胺及其组合物。 本公开的另一方面涉及制备1,5-二异氰酸酯戊烷的方法,其包括使用本文公开的方法制备生物基尸胺,并将生物基尸胺转化为1,5-二异氰酸根戊烷。
    • 7. 发明授权
    • Preparation of cadaverine
    • US09919996B2
    • 2018-03-20
    • US15406900
    • 2017-01-16
    • CATHAY R&D CENTER CO., LTD.CATHAY INDUSTRIAL BIOTECH LTD.
    • Xiucai LiuCharlie LiuBingbing QinNaiqiang LiXiaoMing Li
    • C07C209/84C07C209/86
    • C07C209/84C07C209/86C07C211/09
    • The invention relates to a method for preparing cadaverine comprising: (1) obtaining an aqueous cadaverine salt composition from a fermentation system; (2) adjusting the pH of the aqueous cadaverine salt composition to a pH of at least about 12 by adding an inorganic base composition to provide a first composition comprising an aqueous cadaverine composition having a pH of at least about 12 and a solid composition comprising one or more alkali metal sulfates; (3) subjecting the first composition to solid-liquid separation without organic solvent extraction to provide the aqueous cadaverine composition and the solid composition; (4) distilling or evaporating the aqueous cadaverine composition of step (3) without organic solvent extraction to provide purified cadaverine; (5) preparing a saturated solution of the alkali metal sulfate(s) from the solid composition of step (3) at a temperature of about 35-40° C., mixing the saturated solution with NH4HCO3, and subjecting the mixture to solid-liquid separation to provide Solution (I) and Solid (I); (6) adjusting the temperature of Solution (I) to about 60-80° C., and obtaining Solution (II) and Solid (II) after solid-liquid separation; (7) concentrating Solution (II) and obtaining Solution (III) and Solid (III) after solid-liquid separation; and (8) adding Solid (III) back to the fermentation system of step (1); wherein steps (1) to (8) are optionally repeated one or more times.